Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Medtide, Inc. Class H ( (HK:3880) ) is now available.
Medtide Inc. has received a filing notice from the China Securities Regulatory Commission confirming completion of the regulatory filing for its H share full circulation plan, paving the way for the conversion of its domestic shares into H shares and their listing in Hong Kong. While the detailed implementation plan for the conversion and listing has yet to be finalized and remains subject to additional procedures and approvals from the CSRC, the Hong Kong Stock Exchange and other regulators, the move signals further progress in enhancing the company’s share liquidity and aligning its capital structure with Hong Kong capital market practices, though shareholders are cautioned about the remaining regulatory and execution risks.
The most recent analyst rating on (HK:3880) stock is a Hold with a HK$38.00 price target. To see the full list of analyst forecasts on Medtide, Inc. Class H stock, see the HK:3880 Stock Forecast page.
More about Medtide, Inc. Class H
Medtide Inc. is a joint stock company incorporated in the People’s Republic of China with limited liability and listed in Hong Kong under stock code 3880. The company has a board composed of executive, non-executive and independent non-executive directors, reflecting a typical governance structure for a Hong Kong-listed mainland issuer, though the specific industry and main products or services are not disclosed in this announcement.
Average Trading Volume: 145,385
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$3.52B
See more data about 3880 stock on TipRanks’ Stock Analysis page.